New COVID-19 Research

As the COVID-19 outbreak continues and the race for a vaccine is in full swing, other treatments for the virus are often overlooked. While a vaccine will make people immune to the disease, we should be exploring other treatments that could help people who are already sick survive the illness and potentially save lives right now.

Recently, research teams at Israel’s Hebrew University of Jerusalem, working in conjunction with New York’s Mount Sinai Medical Center on COVID-19 treatments and therapeutics, released a study that suggests the FDA-approved cholesterol drug Fenofibrate, the generic form of the brand name drug Tricor, may significantly downgrade COVID-19’s severity and symptoms.

After three months of testing several FDA-approved drugs, the research team found that Fenofibrate (Tricor) caused the cells within the lungs to start burning fat, which significantly reduced COVID-19’s ability to reproduce and survive. The researchers stated that “the virus almost completely disappeared within only five days of treatment”, according to the Jerusalem Post. The lab studies were conducted in both Israel and New York and were replicated several times with different samples of human lung tissue.

Because the drug is already FDA tested and approved, this research has the potential to help us combat COVID-19 sooner rather than later. I hope that other researchers, including those at the Centers for Disease Control and Prevention (CDC) will pursue this lead and other leads we have to lessen the ill-effects of COVID-19.

Click here to read my press release

Click here to read the Jerusalem Post article

Click here to read the article published by Pharmaceutical-technology.com

Don't Forget the Census!

The United States conducts the Census every 10 years in order to accurately account for its citizens, determine Congressional districts and many more important reasons. It's important that we get the information right and as many people as possible participate. Each household in the country is asked to complete the Census online, by phone or by mail. It will only take approximately ten minutes for you to complete the Census to ensure you and your family members are counted. In March, each mailing address in the country was sent a unique code in order to fill out the questionnaire. If you did not receive this code, click here to retrieve it.

Weekly Roundup

I joined every member of Wisconsin's Congressional Delegation in sending a bipartisan letter to Kenneth Braithwaite, the U.S. Secretary of the Navy, requesting one of the two new Virginia class submarines currently under construction be named the USS Wisconsin. You can read the letter by click here.

Sunday was National Ice Cream Day! Whether vanilla or chocolate, cup or cone, what’s better than ice cream on a hot Wisconsin summer day?

I’m glad I was able to meet with the Wisconsin Future Farmers of America to talk about the future of agriculture and how these young farmers will contribute to the industry for decades to come.

In a hearing for the House Committee on Oversight and Reform, I spoke with Ambassador for Global Women’s Issues Kelly Currie about human rights abuses around the world, specifically those affecting women. Ambassador Currie spoke about the atrocities, like forced sterilization, being committed by the Chinese Communist Party (CCP) against Uighur Muslim women and other ethnic minorities. The CCP's treatment of these people is genocide and these human rights abuses must be brought to light in order to end them. Click here or below to watch

Contact Me

As your Congressman, I’m here to serve you. If you have any questions please don’t hesitate to reach out to my offices in Fond du Lac and Washington. If you enjoyed this newsletter be sure to forward it to your family and friends so they can stay informed on what I’m doing in Washington and the Sixth District.

You can also stay up-to-the-minute by following me on Facebook (Congressman Glenn Grothman), Twitter (@RepGrothman) and Instagram (@RepGlennGrothman).

Sincerely,

Member of Congress